Dalfampridine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Dalfampridine. Educational only — not medical advice.
Labeled uses
Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14) ].
Source: FDA labeling via NIH DailyMed (set ed826777…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.